![Pavel Raifeld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pavel Raifeld
Directeur Général chez
INNOVIVA, INC.
Fortune : 6 M $ au 31/07/2026
Profil
Mr. Pavel Raifeld, CFA MBA, is a Chief Executive Officer & Director at La Jolla Pharmaceutical Co., a President & Director at Entasis Therapeutics Holdings, Inc., a Chief Executive Officer & Director at Innoviva, Inc., a Chief Executive Officer at Theravance Respiratory Co. LLC, a President & Director at Entasis Therapeutics, Inc. and a President & Director at Tetraphase Pharmaceuticals, Inc. He is on the Board of Directors at La Jolla Pharmaceutical Co., Entasis Therapeutics Holdings, Inc., Innoviva, Inc., Entasis Therapeutics, Inc. and Tetraphase Pharmaceuticals, Inc. Mr. Raifeld was previously employed as a Senior Member-Healthcare Investment Banking by Credit Suisse Securities (USA) LLC.
He received his undergraduate degree from Harvard University and an MBA from The Trustees of Columbia University in The City of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INNOVIVA, INC. 0,39 % | 20/05/2026 | 285 929 ( 0,39 % ) | 6 M $ | 31/07/2026 |
Postes actifs de Pavel Raifeld
| Sociétés | Poste | Début |
|---|---|---|
| INNOVIVA, INC. | Directeur Général | 20/05/2020 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | President | 11/07/2022 |
| LA JOLLA PHARMACEUTICAL COMPANY | Directeur Général | 01/04/2023 |
| TETRAPHASE PHARMACEUTICALS, INC. | President | - |
Theravance Respiratory Co. LLC
 Theravance Respiratory Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures inhaled corticosteroid products | Directeur Général | - |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | President | - |
Anciens postes connus de Pavel Raifeld
| Sociétés | Poste | Fin |
|---|---|---|
Credit Suisse Securities (USA) LLC
 Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services | Corporate Officer/Principal | - |
Formation de Pavel Raifeld
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Credit Suisse Securities (USA) LLC
Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services | Finance |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Theravance Respiratory Co. LLC
Theravance Respiratory Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures inhaled corticosteroid products | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
